Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113–23. Mar 2
Article CAS PubMed Google Scholar
MacLeod RAF, Nagel S, Kaufmann M, Janssen JWG, Drexler HG. Activation of HOX11L2 by juxtaposition with 3’-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer. 2003;37:84–91. May 1
Article CAS PubMed Google Scholar
Cheng L, Samad OA, Xu Y, Mizuguchi R, Luo P, Shirasawa S, et al. Lbx1 and Tlx3 are opposing switches in determining GABAergic versus glutamatergic transmitter phenotypes. Nat Neurosci. 2005;8:1510–5. Nov
Article CAS PubMed Google Scholar
Smits WK, Vermeulen C, Hagelaar R, Kimura S, Vroegindeweij EM, Buijs-Gladdines JGCAM, et al. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia. Cell Rep. 2023;42:112373.
Botten GA, Zhang Y, Dudnyk K, Kim YJ, Liu X, Sanders JT, et al. Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription. Blood. 2023;142:336–51.
CAS PubMed PubMed Central Google Scholar
Göös H, Kinnunen M, Salokas K, Tan Z, Liu X, Yadav L, et al. Human transcription factor protein interaction networks. Nat Commun. 2022;13:766.
Dadi S, Le Noir S, Payet-Bornet D, Lhermitte L, Zacarias-Cabeza J, Bergeron J, et al. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression. Cancer Cell. 2012;21:563–76.
Article CAS PubMed Google Scholar
Shimomura A, Patel D, Wilson SM, Koehler KR, Khanna R, Hashino E. Tlx3 promotes glutamatergic neuronal subtype specification through direct interactions with the chromatin modifier CBP. PLoS ONE. 2015;10:10.
Renou L, Boelle P, Deswarte C, Spicuglia S, Benyoucef A, Calvo J, et al. Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia. Blood Adv. 2017;1:733–47.
Article CAS PubMed PubMed Central Google Scholar
Jennings BH, Ish-Horowicz D. The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 2008;9:205.
Article PubMed PubMed Central Google Scholar
Palaparti A, Baratz A, Stifani S. The Groucho/transducin-like enhancer of split transcriptional repressors interact with the genetically defined amino-terminal silencing domain of histone H3. J Biol Chem. 1997;272:26604–10.
Article CAS PubMed Google Scholar
Chen G, Fernandez J, Mische S, Courey AJ. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in Drosophila development. Genes Dev. 1999;13:2218–30.
Article CAS PubMed PubMed Central Google Scholar
Yu X, Li P, Roeder RG, Wang Z. Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split. Mol Cell Biol. 2001;21:4614–25.
Article CAS PubMed PubMed Central Google Scholar
Daniels DL, Weis WI. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol. 2005;12:364–71.
Article CAS PubMed Google Scholar
Cai Y, Brophy PD, Levitan I, Stifani S, Dressler GR. Groucho suppresses Pax2 transactivation by inhibition of JNK-mediated phosphorylation. EMBO J. 2003;22:5522–9. Oct 15
Article CAS PubMed PubMed Central Google Scholar
Riz I, Lee HJ, Baxter KK, Behnam R, Hawley TS, Hawley RG. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors. Biochem Biophys Res Commun. 2009;380:361. Mar 6
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211–8.
Article CAS PubMed PubMed Central Google Scholar
Touzart A, Mayakonda A, Smith C, Hey J, Toth R, Cieslak A, et al. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup. Sci Transl Med. 2021;13:eabc4834.
Bornschein S, Demeyer S, Stirparo R, Gielen O, Vicente C, Geerdens E, et al. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system. Leukemia. 2018;32:941.
Article CAS PubMed PubMed Central Google Scholar
Palomero T, Wei KL, Odom DT, Sulis ML, Real PJ, Margolin A, et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA. 2006;103:18261–6.
Article CAS PubMed PubMed Central Google Scholar
Bonnet M, Loosveld M, Montpellier B, Navarro JM, Quilichini B, Picard C, et al. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood. 2011;117:6650–9.
Article CAS PubMed Google Scholar
Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014;20:1130–7.
Article CAS PubMed PubMed Central Google Scholar
Staal FJT, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC. Transcriptional control of t lymphocyte differentiation. Stem Cells. 2001;19:165–79.
Article CAS PubMed Google Scholar
Zhang Y, Qian JJ, Zhou YL, Huang X, Li JH, Li XY, et al. Comparison of early T-cell precursor and non-ETP subtypes among 122 Chinese adults with acute lymphoblastic leukemia. Front Oncol. 2020;10:1423.
Article PubMed PubMed Central Google Scholar
Van Thillo Q, De Bie J, Seneviratne JA, Demeyer S, Omari S, Balachandran A, et al. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia. Nat Commun. 2021;12:4164.
Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nat Genet. 2022;54:1376–89.
Article CAS PubMed PubMed Central Google Scholar
de Bock CE, Demeyer S, Degryse S, Verbeke D, Sweron B, Gielen O, et al. HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development. Cancer Discov. 2018;8:616–31.
Thielemans N, Demeyer S, Mentens N, Gielen O, Provost S, Cools J. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia. Haematologica. 2022;107:2304–17.
Article CAS PubMed PubMed Central Google Scholar
Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564–576.e16.
Article CAS PubMed PubMed Central Google Scholar
Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147–56.
Article CAS PubMed PubMed Central Google Scholar
Copley RR. The EH1 motif in metazoan transcription factors. BMC Genom. 2005;6:169.
Shimeld SM. A transcriptional modification motif encoded by homeobox and fork head genes. FEBS Lett. 1997;410:124–5.
Article CAS PubMed Google Scholar
Gehre N, Nusser A, von Muenchow L, Tussiwand R, Engdahl C, Capoferri G, et al. A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo. Eur J Immunol. 2015;45:932–42.
留言 (0)